The research, published Sept. 26 in the European Heart Journal, analyzed data from 7.7 million liveborn children, including over 171,000 born after ART. The study is based on data from several high-quality national registries in Nordic countries including Denmark, Finland, Norway and Sweden, and investigates the occurrence of CHDs in children conceived with various ART methods compared to those conceived spontaneously.
The study found that children conceived through ART had a higher occurrence of CHDs compared to those conceived naturally. Researchers also found that children from multiple pregnancies, regardless of the conception method, had the highest risk of CHDs.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
